• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在重度肥胖患者中,胰岛素抵抗和代谢综合征与非酒精性脂肪性肝病相关,但与内脏脂肪指数无关。

Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients.

作者信息

Díez-Rodríguez Rubén, Ballesteros-Pomar María Dolores, Calleja-Fernández Alicia, González-De-Francisco Tomás, González-Herráez Luis, Calleja-Antolín Sara, Cano-Rodríguez Isidoro, Olcoz-Goñi José Luis

出版信息

Rev Esp Enferm Dig. 2014 Dec;106(8):522-8.

PMID:25544409
Abstract

The visceral adiposity index (VAI) is a marker of visceral fat distribution and dysfunction. Visceral adiposity is related to nonalcoholic fatty liver disease (NAFLD); however, there is some controversy regarding the association between VAI and NAFLD.The aim of this study was to analyse the relationship between VAI and NAFLD and to describe the related factors in severely obese patients. A total of 139 patients who underwent bariatric surgery were included in this cross-sectional study. Liver biopsy was performed during surgery. Univariate and multivariate analysis were conducted to study the features related to VAI. A univariate analysis was conducted to identify which factors were associated with liver histology. In the univariate analysis, steatosis, liver inflammation, non-alcoholic steatohepatitis (NASH) and fibrosis were associated with VAI. In the multivariate analysis, only HOMA (Beta: 0.06; p < 0.01) and metabolic syndrome (Beta: 1.23; p < 0.01) were related to VAI. HOMA, the presence of metabolic syndrome, and waist circumference (WC) were statistically related to the NAFLD activity score (NAS score): HOMA: 0-2: 5.04; 3-4: 7.83; > or = 5: 11,32; p < 0.01; MS: 0-2: 37 %; 3-4: 33.3 %; > or = 5: 76%; p < 0.01; WC: 0-2: 128.7 cm; 3-4: 130.7; > or = 5: 140.6; p < 0.01). For the prediction of NASH (NAS score > or = 5), the AUROC curve were 0.71 (CI 95 %: 0.63-0.79) for VAI and 0.7 (CI 95 %: 0.62-0.78) for WC. In conclusion, HOMA, WC and metabolic syndrome are related to liver histology in patients with severe obesity. In the multivariate analysis, VAI was associated with HOMA and metabolic syndrome, but not with liver histology.

摘要

内脏脂肪指数(VAI)是内脏脂肪分布和功能障碍的一个标志物。内脏肥胖与非酒精性脂肪性肝病(NAFLD)相关;然而,关于VAI与NAFLD之间的关联存在一些争议。本研究的目的是分析VAI与NAFLD之间的关系,并描述重度肥胖患者的相关因素。本横断面研究纳入了139例行减肥手术的患者。手术期间进行了肝活检。进行单因素和多因素分析以研究与VAI相关的特征。进行单因素分析以确定哪些因素与肝脏组织学相关。在单因素分析中,脂肪变性、肝脏炎症、非酒精性脂肪性肝炎(NASH)和纤维化与VAI相关。在多因素分析中,只有稳态模型评估胰岛素抵抗(HOMA)(β:0.06;p<0.01)和代谢综合征(β:1.23;p<0.01)与VAI相关。HOMA、代谢综合征的存在以及腰围(WC)与NAFLD活动评分(NAS评分)在统计学上相关:HOMA:0 - 2:5.04;3 - 4:7.83;≥5:11.32;p<0.01;代谢综合征:0 - 2:37%;3 - 4:33.3%;≥5:76%;p<0.01;WC:0 - 2:128.7厘米;3 - 4:130.

相似文献

1
Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients.在重度肥胖患者中,胰岛素抵抗和代谢综合征与非酒精性脂肪性肝病相关,但与内脏脂肪指数无关。
Rev Esp Enferm Dig. 2014 Dec;106(8):522-8.
2
Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.内脏脂肪指数不能预测非酒精性脂肪性肝病患者的肝脏组织学变化。
J Hepatol. 2012 Aug;57(2):392-8. doi: 10.1016/j.jhep.2012.03.013. Epub 2012 Apr 17.
3
Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.在非酒精性脂肪性肝病的非糖尿病患者中,胰岛素抵抗而非内脏脂肪指数与肝纤维化相关。
Metab Syndr Relat Disord. 2015 Sep;13(7):319-25. doi: 10.1089/met.2015.0018. Epub 2015 May 26.
4
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease.内脏脂肪指数与非酒精性脂肪性肝病患者的显著纤维化相关。
Aliment Pharmacol Ther. 2012 Jan;35(2):238-47. doi: 10.1111/j.1365-2036.2011.04929.x. Epub 2011 Nov 24.
5
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤,及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
6
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.非酒精性脂肪性肝病伴低内脏性肥胖患者的非酒精性脂肪性肝炎和纤维化风险。
J Hepatol. 2011 Jun;54(6):1244-9. doi: 10.1016/j.jhep.2010.09.037. Epub 2010 Nov 11.
7
Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.重度肥胖青少年行袖状胃切除术与非酒精性脂肪性肝炎相关特征。
Surg Obes Relat Dis. 2017 Sep;13(9):1599-1609. doi: 10.1016/j.soard.2017.04.005. Epub 2017 Apr 7.
8
Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.无代谢综合征的严重肥胖受试者中经活检证实的非酒精性脂肪性肝病患病率
Clin Obes. 2016 Apr;6(2):117-23. doi: 10.1111/cob.12132. Epub 2016 Feb 8.
9
PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.PNPLA3基因分型增加了非酒精性脂肪性肝病肥胖患者患非酒精性脂肪性肝炎的易感性。
Surg Obes Relat Dis. 2015 Jul-Aug;11(4):888-94. doi: 10.1016/j.soard.2014.07.016. Epub 2014 Aug 1.
10
Visceral Adiposity Index As a Practical Tool in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.内脏脂肪指数作为经肝活检证实的非酒精性脂肪性肝病/非酒精性脂肪性肝炎患者的一种实用工具。
Metab Syndr Relat Disord. 2021 Feb;19(1):26-31. doi: 10.1089/met.2020.0054. Epub 2020 Sep 7.

引用本文的文献

1
Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.非酒精性脂肪性肝病与肝纤维化分期。
Adv Exp Med Biol. 2024;1460:539-574. doi: 10.1007/978-3-031-63657-8_18.
2
Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003-2018): cross-sectional study.年龄、性别和种族在美国成年人中非酒精性脂肪性肝病与内脏脂肪指数相关性中的作用(NHANES 2003-2018):横断面研究。
BMJ Open. 2022 Mar 21;12(3):e058517. doi: 10.1136/bmjopen-2021-058517.
3
Determination of "indeterminate score" measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia.
沙特阿拉伯西部瘦型非酒精性脂肪性肝病患者“不确定评分”测量的确定
World J Hepatol. 2021 Dec 27;13(12):2150-2160. doi: 10.4254/wjh.v13.i12.2150.
4
The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis.非酒精性脂肪性肝病和肝纤维化中的内脏脂肪指数——系统评价与荟萃分析
Biomedicines. 2021 Dec 13;9(12):1890. doi: 10.3390/biomedicines9121890.
5
Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population.腰围身高比是西方中国男性人群代谢相关脂肪性肝病的最佳人体测量指标。
Lipids Health Dis. 2021 Oct 27;20(1):145. doi: 10.1186/s12944-021-01568-9.
6
The Accuracy of Visceral Adiposity Index for the Screening of Metabolic Syndrome: A Systematic Review and Meta-Analysis.内脏脂肪素指数筛查代谢综合征的准确性:一项系统评价与Meta分析
Int J Endocrinol. 2021 Jul 26;2021:6684627. doi: 10.1155/2021/6684627. eCollection 2021.
7
Which Metabolic Index is Appropriate for Predicting Non-alcoholic Steatohepatitis?哪种代谢指标适合预测非酒精性脂肪性肝炎?
Middle East J Dig Dis. 2020 Apr;12(2):99-105. doi: 10.34172/mejdd.2020.168.
8
Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome.在多囊卵巢综合征女性中,脂质积聚产物与通过受控衰减参数量化的肝脂肪变性独立相关。
Endocr Connect. 2020 Feb;9(2):154-162. doi: 10.1530/EC-19-0559.
9
Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.ELF检测在疑似非酒精性脂肪性肝病的病态肥胖患者中检测脂肪性肝炎的效用
Obes Surg. 2017 Sep;27(9):2347-2353. doi: 10.1007/s11695-017-2606-9.
10
Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis.磷脂酰乙醇胺N-甲基转移酶不足是瘦型非酒精性脂肪性肝炎的风险因素。
Sci Rep. 2016 Feb 17;6:21721. doi: 10.1038/srep21721.